Overall, the ZEB1 and ZEB2 transcription factors play important roles in the progression and aggressiveness of acute myeloid leukemia (AML) by influencing the epithelial–mesenchymal transition, stem cell characteristics, and therapy resistance. Here, ZEB2 is linked to acute myeloid leukemia.